Effect of acute and chronic administration of methylphenidate on mitochondrial respiratory Chain in the brain of young rats

Neurochemical Research

Volumn 35, Issue 11, 2010, Pages 1675-1680

  Fagundes, Ana O ^a   Aguiar, Maira R ^a   Aguiar, Claudia S ^a   Scaini, Giselli ^a   Sachet, Monique U ^a   Bernhardt, Nayara M ^a   Rezin, Gislaine T ^a   Valvassori, Samira S ^a   Quevedo, João ^a   Streck, Emilio L ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Brain; Metabolism; Methylphenidate; Mitochondrial respiratory chain

Indexed keywords

CYTOCHROME C OXIDASE; METHYLPHENIDATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN MITOCHONDRION; CEREBELLUM; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; RESPIRATORY CHAIN;

ANIMALS; BRAIN; CEREBELLUM; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX III; MALE; METHYLPHENIDATE; MITOCHONDRIA; PREFRONTAL CORTEX; RATS;

RATTUS;

EID: 78449309494     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0229-9     Document Type: Article

References (73)

1. MF Beal 1992 Does impairment of energy metabolism result in excitotoxic neuronal death in neurological illnesses? Ann Neurol 1 119 130 10.1002/ana.410310202
2. MF Beal 2005 Mitochondria take center stage in aging and neurodegeneration Ann Neurol 58 495 505 1:CAS:528:DC%2BD2MXhtFGrs7fE 10.1002/ana.20624 16178023
3. JP Blass 2001 Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J Neurosci Res 66 851 856 1:CAS:528:DC%2BD3MXpt1Sgt78%3D 10.1002/jnr.10087 11746411
4. JP Blass 2002 Glucose/mitochondria in neurological conditions Int Rev Neurobiol 51 325 376 1:CAS:528:DC%2BD38XpsVyisL8%3D 10.1016/S0074-7742(02)51010- 2 12420364
5. SJ Heales JP Bolaños VC Stewart, et al. 1999 Nitric oxide, mitochondria and neurological disease Biochim Biophys Acta 1410 215 228 1:STN:280:DyaK1M7nslCksg%3D%3D 10.1016/S0005-2728(98)00168-6 10076028
6. JM Land JA Morgan-Hughes I Hargreaves, et al. 2004 Mitochondrial disease: a historical, biochemical, and london perspective Neurochem Res 29 483 491 1:CAS:528:DC%2BD2cXpslWhtg%3D%3D 10.1023/B:NERE.0000014819.53972.b0 15038596
7. MT Lin MF Beal 2006 Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 787 795 1:CAS:528:DC%2BD28XhtVyktbbO 10.1038/nature05292 17051205
8. A Schurr 2002 Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia Neurochem Int 41 1 8 1:CAS:528:DC%2BD38Xitlaksb4%3D 10.1016/S0197-0186(01)00142-5 11918966
9. J Biederman E Mick SV Faraone 2000 Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type Am J Psychiatry 157 816 818 1:STN:280:DC%2BD3c3ks12gtw%3D%3D 10.1176/appi.ajp.157.5.816 10784477
10. TD Challman JJ Lipsky 2000 Methylphenidate: its pharmacology and uses Mayo Clin Proc 75 711 721 1:CAS:528:DC%2BD3cXls1Gmtbc%3D 10.4065/75.7.711 10907387
11. EJ Garland 1998 Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices, caveats J Psychopharmacol 12 385 395 1:CAS:528:DyaK1MXpsVSmtA%3D%3D 10.1177/026988119801200410 10065914
12. DJ Safer RP Allen 1989 Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children J Pediatr 115 1003 1008 1:STN:280:DyaK3c%2Fmtl2ktA%3D%3D 10.1016/S0022-3476(89)80759-0 2585214
13. ND Volkow JS Fowler GJ Wang, et al. 2002 Mechanism of action of methylphenidate: insights from PET imaging studies J Atten Disord 6 1 S31 S43 12685517
14. T Wigal JM Swanson R Regino, et al. 1999 Stimulant medications for the treatment of ADHD: efficacy and limitations Ment Retard Dev Disabil Res Rev 5 215 224 10.1002/(SICI)1098-2779(1999)5:3<215::AID-MRDD8>3.0.CO;2-K
15. SV Faraone J Sergeant C Gillberg, et al. 2003 The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2 104 113 16946911
16. S Mannuzza RG Klein A Bessle, et al. 1997 Educational and occupational outcome of hyperactive boys grown up J Am Acad Child Adolesc Psychiatry 36 1222 1227 1:STN:280:DyaK2svjslSltA%3D%3D 10.1097/00004583-199709000-00014 9291723
17. S Mannuzza RG Klein A Bessle, et al. 1998 Adult psychiatric status of hyperactive boys grown up Am J Psychiatry 155 493 498 1:STN:280: DyaK1c3gslKhsA%3D%3D 9545994
18. ND Volkow GJ Wang JS Fowler, et al. 1998 Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate Am J Psychiatry 155 1325 1331 1:STN:280:DyaK1cvjvVWmsA%3D%3D 9766762
19. ND Volkow GJ Wang JS Fowler, et al. 2005 Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder Biol Psychiatry 57 1410 1415 1:CAS:528:DC%2BD2MXltFSrs7o%3D 10.1016/j.biopsych.2004.11.006 15950015
20. LJ Porrino G Lucignani 1987 Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate. Relevance to its action in hyperactive children Biol Psychiatry 22 126 138 1:CAS:528:DyaL2sXps1SrsQ%3D%3D 10.1016/0006-3223(87)90223-X 3814665
21. G Scaini AO Fagundes GT Rezin, et al. 2008 Methylphenidate increases creatine kinase activity in the brain of young and adult rats Life Sci 83 795 800 1:CAS:528:DC%2BD1cXhtlylu7jO 10.1016/j.lfs.2008.09.019 18938183
22. AO Fagundes GT Rezin F Zanette, et al. 2007 Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats Int J Dev Neurosci 25 47 51 1:CAS:528:DC%2BD2sXht1Oksb4%3D 10.1016/j.ijdevneu. 2006.11.001 17188451
23. TD Chase RE Brown N Carrey, et al. 2003 Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats Neuroreport 14 769 772 1:CAS:528:DC%2BD3sXivVCksro%3D 10.1097/00001756- 200304150-00022 12692480
24. MR Gerasimov M Franceschi ND Volkow, et al. 2000 Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor Synapse 38 432 437 1:CAS:528:DC%2BD3cXotV2msLg%3D 10.1002/1098-2396(20001215)38:4<432::AID-SYN8>3.0.CO;2-Q 11044890
25. SS Valvassori BN Frey MR Martins, et al. 2007 Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats Behav Pharmacol 18 205 212 1:CAS:528:DC%2BD2sXktFOnt7w%3D 10.1097/FBP.0b013e328153daf5 17426484
26. OH Lowry NJ Rosebrough AL Farr, et al. 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 267 1:CAS:528:DyaG38XhsVyrsw%3D%3D 14907713
27. A Cassina R Radi 1996 Differential inhibitory Aation of nitric oxide and peroxynitrite on mitochondrial electron transport Arch Biochem Biophys 328 309 316 1:CAS:528:DyaK28Xit1Klt7w%3D 10.1006/abbi.1996.0178 8645009
28. JC Fischer W Ruitenbeek JA Berden, et al. 1985 Differential investigation of the capacity of succinate oxidation in human skeletal muscle Clin Chim Acta 153 23 26 1:CAS:528:DyaL28Xhs1yhsw%3D%3D 10.1016/0009-8981(85)90135-4 3000647
29. P Rustin D Chretien T Bourgeron, et al. 1994 Biochemical and molecular investigations in respiratory chain deficiencies Clin Chim Acta 228 35 51 1:CAS:528:DyaK2cXltlWjsLc%3D 10.1016/0009-8981(94)90055-8 7955428
30. Greenhill LL (2001) Clinical effects of stimulant medication in attention-deficit/hyperactivity disorder (ADHD). In: Solanto MV, Arnsten AFT, Castellanos FX (eds) Stimulant drugs and ADHD: basic and clinical neuroscience. Oxford University Press, New York, pp 31-71
31. ND Volkow 2006 Stimulant medications: how to minimize their reinforcing effects? Am J Psychiatry 163 359 361 10.1176/appi.ajp.163.3.359 16513852
32. LC Botly CL Burton Z Rizos, et al. 2008 Characterization of methylphenidate self-administration and reinstatement in the rat Psychopharmacology 199 55 66 1:CAS:528:DC%2BD1cXnvVKgsr0%3D 10.1007/s00213-008- 1093-z 18483809
33. M Yano H Steiner 2007 Methylphenidate and cocaine: the same effects on gene regulation? Trends Pharmacol Sci 28 588 596 1:CAS:528:DC%2BD2sXht1KgsLrP 10.1016/j.tips.2007.10.004 17963850
34. GF Koob PP Sanna FE Bloom 1998 Neuroscience of addiction Neuron 21 467 476 1:CAS:528:DyaK1cXms1ehtr0%3D 10.1016/S0896-6273(00)80557-7 9768834
35. RA Wise MA Bozarth 1987 A psychomotor stimulant theory of addiction Psychol Rev 94 469 492 1:STN:280:DyaL1c%2FmvFShtg%3D%3D 10.1037/0033-295X.94.4. 469 3317472
36. MM Schweri P Skolnick MF Rafferty, et al. 1985 [3H]Threo-(±)- methylphenidate binding to 3, 4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters J Neurochem 45 1062 1070 1:CAS:528:DyaL2MXmtVKhtLs%3D 10.1111/j.1471-4159.1985. tb05524.x 4031878
37. R Kuczenski DS Segal 1997 Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine J Neurochem 68 2032 2037 1:CAS:528:DyaK2sXivVSjsb4%3D 10.1046/j.1471-4159.1997.68052032.x 9109529
38. ND Volkow GJ Wang JS Fowler, et al. 1999 Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain Life Sci 65 7 12 10.1016/S0024-3205(99)00225-8
39. ND Volkow G Wang JS Fowler, et al. 2001 Therapeutic doses of oral methylphenidate significantly increases extracellular dopamine in the human brain J Neurosci 21 121
40. CL Brandon M Marinelli KL Baker, et al. 2001 Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats Neuropsychopharmacology 25 651 661 1:CAS:528:DC%2BD3MXnslCjsb8%3D 10.1016/S0893-133X(01)00281-0 11682248
41. R Kuczenski DS Segal 2001 Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine J Pharmacol Exper Ther 296 876 883 1:CAS:528: DC%2BD3MXhtlOksrg%3D
42. CA Crawford SA McDougall TL Meier, et al. 1998 Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum Psychopharmacology 136 34 43 1:CAS:528:DyaK1cXhslelsL4%3D 10.1007/s002130050536 9537680
43. SA McDougall RL Collins PE Karper, et al. 1999 Effects of repeated methylphenidate treatment in the young rat: sensitization of both locomotor activity and stereotyped sniffing Exp Clin Psychopharmacol 7 208 218 1:CAS:528:DyaK1MXlvVOgs78%3D 10.1037/1064-1297.7.3.208 10472508
44. JM Brown BK Yamamoto 2003 Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress Pharmacol Ther 99 45 53 1:CAS:528:DC%2BD3sXksVegsr8%3D 10.1016/S0163-7258(03)00052-4 12804698
45. G Fukami K Hashimoto K Koike, et al. 2004 Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine Brain Res 1016 90 95 1:CAS:528: DC%2BD2cXltl2htro%3D 10.1016/j.brainres.2004.04.072 15234256
46. HS Kim WK Park 1995 Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice J Pharmacol Exp Ther 275 551 557 1:CAS:528:DyaK2MXpsF2htbw%3D 7473138
47. E Przegalinski M Filip 1997 Nitric oxide (NO) pathway and locomotor hyperactivity towards dopaminomimetics in rats Pol J Pharmacol 49 291 298 1:CAS:528:DyaK2sXnslelsb4%3D 9566027
48. CM Pudiak MA Bozarth 2002 The effect of nitric oxide synthesis inhibition on intravenous cocaine self-administration Prog Neuropsychopharmacol Biol Psychiatry 26 189 196 1:CAS:528:DC%2BD38XlvVKhtg%3D%3D 10.1016/S0278-5846(01) 00251-2 11853111
49. MJ LaVoie TG Hastings 1999 Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine J Neurosci 19 1484 1491 1:CAS:528:DyaK1MXhtFOgtbY%3D 9952424
50. G Page M Peeters M Najimi, et al. 2001 Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes J Neurochem 76 5 1282 1290 1:CAS:528:DC%2BD3MXhvVCjtLo%3D 10.1046/j.1471-4159.2001.00179.x 11238713
51. MB Spina G Cohen 1989 Dopamine turnover and glutathione oxidation: implications for Parkinson disease Proc Natl Acad Sci USA 86 1398 1400 1:CAS:528:DyaL1MXhtleju7o%3D 10.1073/pnas.86.4.1398 2919185
52. V Adam-Vizi 2005 Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources Antioxid Redox Signal 7 1140 1149 1:CAS:528: DC%2BD2MXos1eqsLo%3D 10.1089/ars.2005.7.1140 16115017
53. A Navarro A Boveris 2007 The mitochondrial energy transduction system and the aging process Am J Physiol Cell Physiol 292 C670 C686 1:CAS:528: DC%2BD2sXjt1Gmtbw%3D 10.1152/ajpcell.00213.2006 17020935
54. M Gruno N Peet A Tein, et al. 2008 Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells J Gastroenterol 43 780 788 1:CAS:528:DC%2BD1cXht12rs7fP 10.1007/s00535-008-2231-4 18958547
55. T Sen N Sen S Jana, et al. 2007 Depolarization and cardiolipin depletion in aged rat brain mitochondria: relationship with oxidative stress and electron transport chain activity Neurochem Int 50 719 725 1:CAS:528:DC%2BD2sXjsVGjtr4%3D 10.1016/j.neuint.2007.01.007 17331620
56. SB Berman TG Hastings 1999 Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J Neurochem 73 1127 1137 1:CAS:528:DyaK1MXlsVOitL4%3D 10.1046/j.1471-4159.1999.0731127.x 10461904
57. JH Prehn 1998 Mitochondrial transmembrane potential and free radical production in excitotoxic neurodegeneration Naunyn-Schmiedeberg's Arch Pharmacol 357 316 322 1:CAS:528:DyaK1cXhtlOqsLY%3D 10.1007/PL00005173
58. G Barja A Herrero 1998 Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon J Bioenerg Biomembr 30 235 243 1:CAS:528:DyaK1cXlslehtL8%3D 10.1023/A:1020592719405 9733090
59. B Gassner A Wuthrich G Scholtysik, et al. 1997 The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I J Pharmacol Exp Ther 281 855 860 1:CAS:528:DyaK2sXjtFynurg%3D 9152394
60. TB Sherer R Betarbet JH Kim, et al. 2003 Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation Exp Neurol 179 9 16 1:CAS:528:DC%2BD38Xps12ku74%3D 10.1006/exnr.2002.8072 12504863
61. G Lenaz C Bovina C Castelluccio, et al. 1997 Mitochondrial complex I defects in aging Mol Cell Biochem 174 329 333 1:CAS:528:DyaK2sXmt1Cjsbk%3D 10.1023/A:1006854619336 9309707
62. MR Martins A Reinke FC Petronilho, et al. 2006 Methylphenidate treatment induces oxidative stress in young rat brain Brain Res 1078 189 197 1:CAS:528:DC%2BD28XjtFais7w%3D 10.1016/j.brainres.2006.01.004 16494852
63. JL Madrigal R Olivenza MA Moro, et al. 2001 Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain Neuropsychopharmacology 24 420 429 1:CAS:528:DC%2BD3MXht12gtbg%3D 10.1016/S0893-133X(00)00208-6 11182537
64. RL Torres ILS Torres GD Gamaro, et al. 2004 Lipid peroxidation and total radical-trapping potential of the lungs of rats submitted to chronic and sub-chronic stress Braz J Med Biol Res 37 185 192 1:CAS:528:DC%2BD2cXisFCqtbw%3D 10.1590/S0100-879X2004000200004 14762572
65. EJ Boekema HP Braun 2007 Supramolecular structure of the mitochondrial oxidative phosphorylation system J Biol Chem 282 1 4 1:CAS:528:DC%2BD2sXks1Km 10.1074/jbc.R600031200 17102127
66. DA Marsteller MR Gerasimov WK Schiffer, et al. 2002 Acute handling stress modulates methylphenidate-induced catecholamine overflow in themedial prefrontal cortex Neuropsychopharmacology 27 163 170 1:CAS:528: DC%2BD38XkvFyqtrw%3D 10.1016/S0893-133X(02)00288-9 12093590
67. JE Desmond JA Fiez 1998 Neuroimaging studies of the cerebellum: language, learning, and memory Trends Cogn Sci 2 355 362 10.1016/S1364-6613(98)01211-X
68. FA Middleton PL Strick 2001 Cerebellar projections to the prefrontal cortex of the primate J Neurosci 21 700 712 1:CAS:528:DC%2BD3MXnslCksg%3D%3D 11160449
69. AO Fagundes G Scaini PM Santos, et al. 2010 Inhibition of mitochondrial respiratory chain in the brain of adult rats after acute and chronic administration of methylphenidate Neurochem Res 35 405 411 1:CAS:528: DC%2BD1MXhtFOitrvL 10.1007/s11064-009-0069-7 19777344
70. AC Andreazza NB Frey SS Valvassori, et al. 2007 DNA damage in rats after treatment with methylphenidate Prog Neuropsychopharmacol Biol Psychiatry 31 1282 1288 1:CAS:528:DC%2BD2sXot12qu7k%3D 10.1016/j.pnpbp.2007.05.012 17614179
71. R Kuczenski DS Segal 2002 Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine J Neurosci 22 7264 7271 1:CAS:528:DC%2BD38XmsF2gtr8%3D 12177221
72. WA Carlezon Jr EJ Nestler 2002 Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 25 2002 610 615 1:CAS:528:DC%2BD38XoslCntr8%3D 10.1016/S0166-2236(02)02289-0 12446127
73. EJ Nestler 2001 Molecular basis of long-term plasticity underlying addiction Nat Rev Neurosci 2 119 128 1:CAS:528:DC%2BD3MXisl2qu78%3D 10.1038/35053570 11252991